Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
about
Cholera toxin: a paradigm of a multifunctional proteinCpG oligodeoxynucleotides as mucosal adjuvantsCrosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells.Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoniInhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunitCholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissueMice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.Kinetics of local and systemic immune responses to an oral cholera vaccine given alone or together with acetylcysteine.In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio choleraeGenetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants.Differential regulation of macrophage interleukin-1 (IL-1), IL-12, and CD80-CD86 by two bacterial toxins.Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines.Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infectionComparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines.Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccineDeficient induction of the immune response to oral immunization with cholera toxin in malnourished rats during sucklingEnhancement of anti-Shigella lipopolysaccharide (LPS) response by addition of the cholera toxin B subunit to oral and intranasal proteosome-Shigella flexneri 2a LPS vaccinesMutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functionsAdjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGunOral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.Activation of cholera toxin-specific T cells in vitro.Progress towards development of a vaccine for amebiasis.Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.Oral immunization with a recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence inhibition activity.Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responsesCholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccineDevelopment of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunizationOral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.
P2860
Q24598726-21847BA7-347C-4C9C-8984-3EE070244721Q28086998-6B0B110D-2E02-4B8F-8445-6C79146439FDQ30500371-D25D4A0A-3E56-4E94-9118-78886AF25A12Q33597587-7CC609C5-1B4C-41A9-8566-AA1AB44A37D9Q33611155-1628708A-7EA8-4BEB-A942-D55457BFEFC7Q33615306-389BBD38-B632-4282-8CFD-5C1F8E667E79Q33757092-E586C202-1473-47D4-B39E-826B0F5714A5Q33768109-2E7BE064-E81A-4B5C-AB53-70B04467851BQ33769366-D38D8022-5F0A-4A57-B606-6140A02C7BDBQ33829995-71DDBF75-DEAF-46B7-833D-2D9E5F5B9F73Q33955531-3CAFB814-D040-4B5B-A2CC-5B7BF1D5893FQ33992027-047F7DB8-9393-4DAE-A90A-8FA06B85986DQ34000827-3B0CE1ED-6AB0-4794-9275-C10C5CBFCD32Q34001658-5EC05E6E-760C-44A3-AFF4-BA11AA496D90Q34002122-6BB1E23B-363F-4074-A2CD-9492738BCFB3Q34002438-862040A6-7DB5-4035-A68A-B83313A86AD5Q34002470-839DD213-C3C4-4EBB-AE29-8C53D92DF02CQ34006385-7B161DA1-C5FA-48C6-9839-2F38E260EBE3Q34514011-7B5EC6A1-78CC-4F80-B9C3-2B18DF0486E8Q34520511-C9762EE2-AB0F-41B0-9082-AB684DAD500BQ34522325-3F1A51BC-96ED-4EC4-8D2E-ED8315B81818Q34522757-93913257-F6E3-427A-A1DE-63F9B2FEF45FQ34535349-F5EF1083-AC0C-40BE-B619-D9DAE12B2BEDQ34544650-08F01001-D021-4F4F-82AC-F55FDCB08C5CQ34546234-8DD714B1-B8E0-4BE9-BB00-63A394775D6CQ34715639-9D59E149-8AE9-4FAA-A330-F2BAFFD7A77AQ35066456-52C86552-0B74-4925-ADCA-0DAE28A108BBQ35093806-98166125-4E89-4080-A0C4-32836A071EA9Q35094061-18B34738-8F3D-4235-829C-692F3C45B163Q35107810-F2339A24-966D-4F87-82B1-3D25A4CA7433Q35375735-6F58F067-5714-44C9-AE56-C20C948B9427Q35400277-FA6359C3-0BEA-455B-A6E2-6C54782FD36CQ35414871-CA880910-BE31-479A-92EE-451B78B3EEC9Q35485626-00E57A0D-5240-4CAE-A1BD-C73E8F5AE867Q35486754-B8E0205E-B58B-41A3-9225-C129A7A200EBQ35520692-14B758DD-27A7-4DC5-9178-511EA40ED2C8Q35533881-28A788B3-CD58-45AD-AF3A-42690DFBE9DFQ35543988-E4387447-0E4E-47DA-8CA7-C0C74E62CB9EQ35546011-3C4D3C7C-258D-416A-8B33-DA7190FC0645Q35551202-38C1B4A6-B9E6-433E-B465-34BFB7FB8597
P2860
Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Strong adjuvant properties of ...... to orally presented antigens.
@en
type
label
Strong adjuvant properties of ...... to orally presented antigens.
@en
prefLabel
Strong adjuvant properties of ...... to orally presented antigens.
@en
P1433
P1476
Strong adjuvant properties of ...... to orally presented antigens.
@en
P304
P577
1986-10-01T00:00:00Z